Dan Gorenstein
-
People leaving jail or prison are at extremely high risk of hospitalization and death, and policymakers from deep blue California to solidly red Utah think bringing Medicaid behind bars could help.
-
She's seen what happens when people don't trust or understand their doctor. Dr. Lisa Fitzpatrick founded 'Grapevine Health' to get solid information out, especially to Black and Latinx patients.
-
Drugmakers will be required to pay Medicare back for price increases that outpace inflation. The industry is expected to put up a fight over implementation.
-
U.S. doctors can now choose Amjevita instead, the first of several close copies of the popular rheumatoid arthritis drug expected this year. But industry-watchers warn consumer savings may be limited.
-
The Inflation Reduction Act gives Medicare historic new powers to limit prescription drug prices. But the pharmaceutical industry is already lobbying to dull their impact.
-
Independent funds that help people pay for abortions have been flooded with donations since Roe v. Wade was overturned, but demand and costs are also rising as more states enact restrictive bans.
-
MRIs done early for uncomplicated low back pain and routine vitamin D tests "just to be thorough" are considered "low-value care" and can lead to further testing that can cost patients thousands.
-
A growing number of private insurance companies are starting to invest in medical respite — a decades-old way of caring for homeless people. Here's what's driving the trend.
-
Matching the sickest patients with social workers and medical support doesn't reduce costly hospital readmissions, a study finds. Still, some believe greater social investment could make a difference.
-
Nearly 3 million Americans are caught in the vise grip that is mobile home living — they own their home but rent the land it sits on, making it nearly impossible to build equity. But a nonprofit is organizing co-ops that help transform tenants into homeowners, giving many a sense of stability they'd never experienced before.